Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-23-000018 General Corporate
Debt relative to revenue 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
132.59% · OPTIONAL · VALID
Capex intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
10.40% · OPTIONAL · VALID
Operating cash generation 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-13.03% · OPTIONAL · VALID
Revenue growth 21th Own-history percentile · N=19
Evidence method Yoy · gp.fundamentals.revenue
12.23% · CORE · VALID
Inventory pressure 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
79.65% · OPTIONAL · VALID
Operating margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
6.90% · CORE · VALID
R&D intensity 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.95% · OPTIONAL · VALID
SBC intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.06% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 29.78%
Current 132.59%
Delta 102.80% Capex Intensity Decreased
Previous 13.32%
Current 10.40%
Delta -2.92% Cash Generation Decreased
Previous -0.88%
Current -13.03%
Delta -12.15% Growth Decreased
Previous 27.52%
Current 12.23%
Delta -15.29% Inventory Pressure Increased
Previous 24.01%
Current 79.65%
Delta 55.64% Profitability Increased
Previous 6.43%
Current 6.90%
Delta 0.47% R And D Intensity Increased
Previous 1.91%
Current 1.95%
Delta 0.04% Sbc Intensity Decreased
Previous 1.18%
Current 1.06%
Delta -0.11% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.